Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Taipei Exchange (TPEx) is a prominent financial institution and stock exchange based in Taiwan that operates as a secondary market for over-the-counter (OTC) securities. While not a biotechnology company itself, it is a critical pillar of the global life sciences ecosystem, hosting a dedicated Biotechnology and Medical Care sector that includes numerous pharmaceutical, medical device, and clinical research organizations. TPEx provides essential capital-raising opportunities for emerging growth companies through its Main Board and the Pioneer Stock Board. It is recognized for its specialized listing requirements tailored to the unique research and development cycles of the biotech industry, making it one of the most active hubs for healthcare investment in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taipei Exchange.